anti-TROP-2 antibody-drug conjugate HS-20105

{
  "id": "MLC-T-ONC-011156",
  "term": "anti-TROP-2 antibody-drug conjugate HS-20105",
  "field": "Oncology and biomedicine",
  "definition": "An antibody-drug conjugate (ADC) composed of a humanized immunoglobulin G1 (IgG1) monoclonal antibody targeting the tumor-associated antigen (TAA) trophoblast cell surface protein 2 (trophoblast antigen 2; calcium signal transducer 2; TROP2; TROP-2; TACSTD2; GA733-1; M1S1) linked, via a cleavable linker, to a topoisomerase-1 inhibitor, with potential antineoplastic activity. Upon administration of anti-TROP-2 ADC HS-20105, the anti-TROP-2 antibody targets and binds to TROP-2 expressed on tumor cells. Upon binding, internalization and linker cleavage, the topoisomerase-1 inhibitor is released, and inhibits DNA topoisomerase-1 activity, thereby inhibiting DNA replication and resulting in cell cycle arrest and tumor cell apoptosis. This inhibits the proliferation of TROP-2-expressing tumor cells. TROP-2 is a transmembrane protein overexpressed in various tumors. Its expression is associated with enhanced tumor aggressiveness, metastasis, drug resistance and increased tumor cell survival.",
  "synonyms": [
    "ADC HS-20105",
    "anti-TROP-2 ADC HS-20105",
    "anti-TROP-2/topoisomerase-1 inhibitor ADC HS-20105"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/anti-trop-2-antibody-drug-conjugate-hs-20105/"
}